Clinical Trial Detail

NCT ID NCT02490930
Title A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

astrocytoma

Therapies

Fingolimod

Age Groups: adult

No variant requirements are available.